Cover of: Insulin-Like Growth Factors (Breast Disease) | Douglas Yee Read Online

Insulin-Like Growth Factors (Breast Disease)

  • 297 Want to read
  • ·
  • 50 Currently reading

Published by IOS Press .
Written in English


  • Physiology,
  • Diseases - Breast Cancer,
  • Consumer Health

Book details:

The Physical Object
Number of Pages124
ID Numbers
Open LibraryOL8819553M
ISBN 10158603409X
ISBN 109781586034092

Download Insulin-Like Growth Factors (Breast Disease)


The insulin-like growth factor 1 (IGF-1) receptor is a protein found on the surface of human cells. It is a transmembrane receptor that is activated by a hormone called insulin-like growth factor 1 (IGF-1) and by a related hormone called IGF It belongs to the large class of tyrosine kinase receptors. Insulin-like growth factor (IGF), formerly called somatomedin, any of several peptide hormones that function primarily to stimulate growth but that also possess some ability to decrease blood glucose levels. IGFs were discovered when investigators began studying the effects of biological substances on cells and tissues outside the body. The name insulin-like growth factor reflects the fact. Insulin-like growth factor 1 (IGF-1), also called somatomedin C, is a hormone similar in molecular structure to insulin which plays an important role in childhood growth, and has anabolic effects in adults.. IGF-1 is a protein that in humans is encoded by the IGF1 gene. IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. 1. Introduction. Insulin and insulin-like growth factor-1 (IGF-1) exert their biological effects by binding to and activating cell surface transmembrane receptors with intrinsic tyrosine kinase activity (Ullrich et al., ; Ullrich et al., ).Activated insulin and IGF-1 receptors phosphorylate a variety of substrates, among which are the IRS (Insulin Receptor Substrate) family of scaffold Cited by:

  Insulin-like growth factor (IGF) can affect your blood glucose levels. IGF may be used as a treatment for diabetes, but more research is necessary. The use of coacervates sufficiently protected a bioactivity of cargo insulin-like growth factor-1 (IGF-1) and regulated its sustained release kinetics in the composite hydrogels Coacervate-mediated delivery of IGF-1 effectively facilitated chondrogenic differentiation of adipose-derived stem cells (ADSCs). 13 hours ago  Mammals have two insulin-like growth factors (IGF) that are key mediators of somatic growth, tissue differentiation, and cellular responses to stress. Thus, the mechanisms that regulate the bioavailability of IGFs are important in both normal and aberrant development. IGF-I levels are primarily controlled via the growth hormone-IGF axis, in response to nutritional status, and also reflect. Insulin-like growth factor (IGF) is a polypeptide hormone similar to insulin. There are two types of insulin-like growth factors, IGF-1 and IGF-2, which are released upon stimulation by the growth hormone. Insulin-like growth factor binds to the IGF-1 or the IGF-2 receptor and the insulin receptor, and promotes growth and development.

Abstract. Until recently, insulin-like growth factors (or, as they were originally known, somatomedins) were thought to be produced in the liver in response to growth hormone, to circulate in the blood, and to mediate the effects of growth hormone (GH) on skeletal cartilage to promote bone elongation during childhood (Salmon and Daughaday ).Cited by:   The insulin-like growth factor (IGF) pathway involves elements of endocrine, paracrine, and autocrine control in regulating fetal development, growth, and metabolism. 1 Growth hormone stimulates production of insulin-like growth factor-1 (IGF-1) in the liver and peripheral tissues. IGF-1 is also released locally in response to damage, either directly or through the action of other factors. insulin-like growth factor binding Source: MGI "Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or ". Insulin-like growth factors (IGFs) and the IGF signaling pathways play a role in development of the normal mammary gland. Numerous studies have now demonstrated that the IGF system regulates all of the key metastatic phenotypes in breast cancer cells: survival, proliferation, and metastasis.